Deciphera Pharmaceuticals, a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, has entered...
The U.S. Food and Drug Administration (FDA) has approved Accord BioPharma's HERCESSI (trastuzumab-strf), a biosimilar to Herceptin (trastuzumab), to treat HER2-overexpressing breast and gastric...